43
Views
21
CrossRef citations to date
0
Altmetric
Articles

Recurrent Respiratory Tract Infections in Pediatric Age: A Population-Based Survey of the Therapeutic Role of Macrolides

Pages 53-59 | Published online: 18 Jul 2013

References

  • Korppi M. Recurrent respiratory infections in children: a practical approach for clinical work. Pediatr Pulmonol 1997; Suppl 16: 144-145.
  • Herrod H, Blaiss M, Valenski W, Gross S. Cell mediated immune status of children with recurrent infection. J Pediatr 1995; 126: 530–536.
  • Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 2002; 156: 121–126.
  • Makela MJ, Puhakka T, Ruuskanen O et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998; 36: 539–542.
  • Tsai HP, Kuo PH, Liu CC, Wang JR. Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 2001; 39: 111–118.
  • Vesa S, Kleemola M, Blomqvist S, Takala A, Kilpi T, Hovi T. Epidemiology of documented viral respiratory infec-tions and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001; 20: 574–581.
  • Esposito S, Blasi F, Arosio C et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infec-tion in children with wheezing. Eur Resp J 2000; 16: 1142–1146.
  • Principi N, Esposito S, Blasi F, Allegra L, the Mowgli Study Group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32: 1281–1289.
  • Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respi-ratory tract infections. Lancet Infect Dis 2001; 1: 334–344.
  • Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis 2002; 15: 295–300.
  • Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, Principi N. Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis. Eur J Clin Microbiol Infect Dis 2002; 96: 780–787.
  • Principi N, Esposito S. Comparative tolerability of ery-thromycin and newer macrolide antibacterials in paediatric patients. Drug Safety 1999; 20: 25–41.
  • File TM, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998; 12: 569–592.
  • Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma. Effect of clarithromycin. Chest 2002; 121: 1782–1788.
  • De Mattia D, Decandia P, Ferrante P et al. Effectiveness of thymostimulin and study of lymphocyte-depen-dent antibacterial activity in children with recurrent respiratory infections. Immunopharmacol Immunotoxicol 1993; 15: 447–459.
  • Feigin RD, Cherry JD, eds. Textbook of pediatric infec-tious diseases. 4th Ed. Philadelphia, PA: W.B. Saunders Company. 1998.
  • Jacobs RF, Schutze GE, Young RA et al. Antimicrobial agents. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. New York, NY: Churchill Livingstone. 1997: 1604-62.
  • Givon-Lavi N, Dagan R, Fraser D, Yagupsky P, Porat N. Marked differences in pneumococcal carriage and resis-tance patterns between day care centers located within a small area. Clin Infect Dis 1999; 29: 1274–1280.
  • Principi N, Marchisio P, Schito GC, Mannelli S, the Ascanius Project Collaborative Group. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy chil-dren. Pediatr Infect Dis J 1999; 18: 517–523.
  • Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient vis-its, and courses of antibiotics in children. N Engl J Med 2000; 342: 225–231.
  • Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory dis-ease among infants and young children. N Engl J Med 2000; 342: 232–239.
  • Hurwitz ES, Haber M, Chang A et al. Effectiveness of influenza vaccination of day care children in reducing influen-za-related morbidity among household contacts. JAMA 2000; 284: 1677–1682.
  • Marchisio P, Cavagna R, Maspes B et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002; 35: 168–174.
  • Valleron AJ, Grimfeld A. Evaluation of clinical trials of immunomodulators for prevention of recurrent respiratory infections in children. Develop Biol Standard 1992; 77: 149–158.
  • Masihi KN. Immunomodulatory agents for prophylaxis and therapy of infections. Intern J Antimicrob Agents 2000; 14: 181–191.
  • Wang EEL, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evi-dence of overprescribing for viral respiratory infections. Clin Infect Dis 1999; 29: 155–160.
  • Wenzel RP, Edmond MB. Managing antibiotic resis-tance. N Engl J Med 2000; 343: 1961–1963.
  • Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999; 18: 258–261.
  • Esposito S, Principi N. Emerging resistance to antibi-otics against respiratory bacteria: impact on therapy of com-munity-acquired pneumonia in children. Drug Res Updates 2002; 239: 1–15.
  • Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy ML. Outcomes after judicious antibiotic use for respi-ratory tract infections seen in a private pediatric practice. Pediatrics 2000; 105: 753–759.
  • Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics 1999; 104: 1251–1257.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.